• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDLINE INDUSTRIES, LP- NAMIC MEDLINE; SYRINGE,10ML,ANGIO,W/RA,-,OEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDLINE INDUSTRIES, LP- NAMIC MEDLINE; SYRINGE,10ML,ANGIO,W/RA,-,OEM Back to Search Results
Catalog Number 80085007
Medical Device Problem Code Loose or Intermittent Connection (1371)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/02/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
According to the customer contact, "hand injection 3 way tap + syringe were well connected at beginning of case then syringe started to become loose and untwist off the manifold during pci.Manifold changed but still issue occurred.Entire kit changed however same issue occurred with new set." due diligence has been completed.No additional details are available related to the customer reported issue.Despite multiple good faith efforts to obtain additional information, the customer contact was unable or unwilling to provide further incident details to the manufacturer.The sample was requested for evaluation.To date, no information has been received to indicate that a user or a patient experienced a death, serious injury, medical intervention, follow-up care, or other adverse health impact associated with the reported problem/issue.In an abundance of caution, and in response to an fda 483 issued for cfn 1417592 on 22-jan-2024, this medwatch is being filed for the reported problem/issue.If additional relevant information becomes available a supplemental medwatch will be filed.
 
Event or Problem Description
According to the customer contact, "hand injection 3 way tap + syringe were well connected at beginning of case then syringe started to become loose and untwist off the manifold during pci.Manifold changed but still issue occurred.Entire kit changed however same issue occurred with new set.".
 
Additional Manufacturer Narrative
Update to h6: investigation findings (c).Update to h6: investigation conclusions (d).Update to h7: if remedial action initiated, check type.Update to h9: if action reported to fda under 21 usc 360i(g), list correction.Removal reporting number.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDLINE
Common Device Name
SYRINGE,10ML,ANGIO,W/RA,-,OEM
Manufacturer (Section D)
MEDLINE INDUSTRIES, LP- NAMIC
10 glens falls technical park
glen falls NY 12801 3864
Manufacturer Contact
alexa huskisson
three lakes drive
northfield, IL 60093
MDR Report Key24491122
Report Number3015910259-2026-00057
Device Sequence Number21504160
Product Code DXT
UDI-Device Identifier10193489066838
UDI-Public10193489066838
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
K873955
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other
Remedial Action Recall
Type of Report Initial,Followup
Report Date (Section B) 03/17/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Catalogue Number80085007
Device Lot Number0000156801
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/02/2026
Supplement Date Received by Manufacturer03/12/2026
Initial Report FDA Received Date03/02/2026
Supplement Report FDA Received Date03/17/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/03/2025
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
R-26-025
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-